Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Apr 11 2023

Full Issue

By 2030, Moderna Aims To Offer Vaccines For Cancer And Heart Disease

A Moderna spokesperson tells CNBC that new vaccines could even come as quickly as five years from now, thanks to advancements in mRNA technology. Other pharmaceutical news is on the Theranos case, cancer drug shortages, Juul, and more.

CNBC: Moderna Hopes To Offer New Vaccines For Cancer, Heart Disease By 2030

Moderna hopes to offer a new set of life-saving vaccines targeting cancer, heart disease and other conditions by 2030, a spokesperson for the company told CNBC on Monday. The spokesperson confirmed remarks Moderna’s chief medical officer, Dr. Paul Burton, made to the Guardian on Saturday. Burton said he’s confident those jabs will be ready by the end of the decade, adding that Moderna could possibly offer them in as little as five years. (Constantino, 4/10)

In updates on the Theranos case —

Bloomberg: Elizabeth Holmes Loses Bid To Remain Free During Appeal 

Elizabeth Holmes must report to prison as scheduled later this month, a judge ruled, rejecting her request to remain free on bail as she appeals her fraud conviction. The decision Monday by US District Judge Edward Davila in San Jose, California, is likely his last in the case which he’s handled since Holmes was indicted in 2018. Davila presided over the Theranos Inc. founder’s four-month trial in 2021 and sentenced her in November to serve 11 1/4 years of incarceration for deceiving investors in her blood-testing startup. (Rosenblatt, 4/11)

In other pharmaceutical industry news —

NBC News: Shortage On 4 Cancer Drugs Creates Dire Scenarios For Patients

Robert Landfair, 76, was diagnosed with Stage 4 prostate cancer in 2018. After several unsuccessful rounds of chemotherapy, his doctor, Alan Tan of Rush University Medical Center in Chicago, recommended that he switch to Pluvicto, a new medication for advanced prostate cancer. But the drug’s manufacturer, Novartis, has had supply problems. Landfair is now on a waitlist for the medication, which isn’t expected to be widely available for several more months. (Lovelace Jr. and Kopf, 4/11)

AP: Vaping Company Juul Settles West Virginia Lawsuit For $7.9M

Vaping company Juul Labs will pay West Virginia $7.9 million to settle a lawsuit alleging the company marketed products to underage users, Attorney General Patrick Morrisey announced Monday. The lawsuit accuses Juul of engaging in unfair or deceptive practices in the design, manufacturing, marketing and sale of e-cigarettes in violation of the state’s Consumer Credit and Protection Act. (Raby, 4/10)

The Washington Post: Black Man Awaiting Kidney Transplant Alleges Racial Bias 

An African American man is seeking millions of dollars in damages and a better position on the kidney transplant waiting list in a lawsuit that claims an algorithm used in determining priority for organs is biased against Black people. Anthony Randall last week sued an affiliate of the Cedars-Sinai hospital in Los Angeles, where he is listed as a transplant patient, and the United Network for Organ Sharing, the nonprofit organization that operates the U.S. transplant system. (Bernstein, 4/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF